An observational study in Abdominal Aortic Aneurysm and Endoleak, sponsored by Norwegian University of Science and Technology. Terminated at 1 site in Norway. Per ClinicalTrials.gov, last updated 2017-10-31.
Sponsored by Norwegian University of Science and Technology · Observational
Among 11 studies in Aortic Aneurysm, Abdominal with a site in Norway — 1 open to participants now, 3 under way, none of them phase 3. Aortic Aneurysm, Abdominal · Norway.
Among the 11 studies in Aortic Aneurysm, Abdominal with a site in Norway, this one is one of 2 that started in 2014, is one of 8 observational ones, and was the 6th registered.
467 studies on the registry are indexed under Aortic Aneurysm, Abdominal; 99 are open to participants now.
This study's enrollment of 30 is below the median of 165 across 217 observational studies indexed under Aortic Aneurysm, Abdominal.
Browse Aortic Aneurysm, Abdominal studies →1 of the 11 studies in Aortic Aneurysm, Abdominal with a site in Norway is open now, in 1 country. Each count lists the studies.
Of the 66 Aortic Aneurysm, Abdominal studies recruiting now, 52 (79%) set no upper age limit and 3 (5%) stop at 75 or younger; 2 take children under 18; 8 take healthy volunteers.
This study: all sexes · no healthy volunteers.
The full table on the hub →11 studies; the count open now beside each. This study's row is marked.
First in 2005; this study’s year is marked. 2 started in 2014.
Median enrollment 20 across the 3 interventional studies, 139 across the 8 observational. Of the 8 that completed or were terminated, 0 (0%) have results posted.
4 of 11 have an industry lead sponsor. The 7 most frequent:
Norwegian University of Science and Technology is the lead sponsor of 495 studies on the registry; 48 are open to participants now.
Norwegian University of Science and Technology has 5 studies filed under Aortic Aneurysm, Abdominal — fewer than ten, so there is no comparison to draw.
1 of the studies in Aortic Aneurysm, Abdominal with a site in Norway that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06403423Sykehuset Innlandet HFScreening for Aortic Aneurysms in Inland Norway | 2027-05-09 |
Among the 11 studies in Aortic Aneurysm, Abdominal with a site in Norway, from their registry updates:
Nothing recorded among them since 2026-09-25.
X-ray computed tomography imaging (CT) is routinely used in follow-up after endovascular aneurysm repair (EVAR). Contrast-enhanced ultrasound (CEUS) has been shown to give accurate information about endoleak after EVAR. Benefits of CEUS over CT include less radiation exposure, avoidance of renal function deterioration due to repeated X-ray contrast agent application and decrease in the cost of EVAR follow-up. This study is designed to investigate if results from literature are reproducible in St Olavs Hospital in Trondheim (Norway), to gain experience with the technique and to introduce CEUS as an alternative for detection of endoleak in this hospital.
All patients in follow-up after endovascular implantation of abdominal aortic prothesis, Central Norway
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Detection of endoleak with CEUS
Compare CEUS with computed tomography angiography (CTA) sensitivity for detection of endoleak
Time frame: 9 months
Ran from Sep 2014 to primary completion in Jun 2017, 33 months.
How these figures are worked out, and which studies are left out of them.
This study is terminated, as verified in Oct 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Norwegian University of Science and Technology →